Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic Leukemia

Pulsipher, MA; Han, X; Maude, SL; Laetsch, TW; Qayed, M; Rives, S; Boyer, MW; Hiramatsu, H; Yanik, GA; Driscoll, T; Myers, GD; Bader, P; Baruchel, A; Buechner, J; Stefanski, HE; Kalfoglou, C; Nguyen, K; Waldron, ER; Mueller, KT; Maier, HJ; Kari, G; Grupp, SA

Pulsipher, MA (通讯作者)，Univ Utah, Huntsman Canc Inst, 2000 Circle Hope Dr, Salt Lake City, UT 84112 USA.

BLOOD CANCER DISCOVERY, 2022; 3 (1): 66

Abstract

We assessed minimal residual disease (MRD) detection and B-cell aplasia after tisagenlecleucel therapy for acute lymphoblastic leukemia (ALL) to defi ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索